Code	Codelist Code	Codelist Extensible (Yes/No)	Codelist Name	CDISC Submission Value	CDISC Synonym(s)	CDISC Definition	NCI Preferred Term
C66767		No	Action Taken with Study Treatment	ACN	Action Taken with Study Treatment	Terminology specifying changes to the study treatment as a result of an adverse event.	CDISC SDTM Action Taken with Study Treatment Terminology
C49503	C66767		Action Taken with Study Treatment	DOSE INCREASED		An indication that a medication schedule was modified by addition; either by changing the frequency, strength or amount. (NCI)	Dose Increased
C49504	C66767		Action Taken with Study Treatment	DOSE NOT CHANGED		An indication that a medication schedule was maintained. (NCI)	Dose Not Changed
C150826	C66767		Action Taken with Study Treatment	DOSE RATE REDUCED		An indication that the administration of a medication was modified by reducing the rate at which the dose was given, without reducing the total dose administered.	Dose Rate Reduced
C49505	C66767		Action Taken with Study Treatment	DOSE REDUCED		An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount. (NCI)	Dose Reduced
C49501	C66767		Action Taken with Study Treatment	DRUG INTERRUPTED		An indication that a medication schedule was modified by temporarily terminating a prescribed regimen of medication. (NCI)	Drug Interrupted
C49502	C66767		Action Taken with Study Treatment	DRUG WITHDRAWN		An indication that a medication schedule was modified through termination of a prescribed regimen of medication. (NCI)	Drug Withdrawn
C48660	C66767		Action Taken with Study Treatment	NOT APPLICABLE	NA; Not Applicable	Determination of a value is not relevant in the current context. (NCI)	Not Applicable
C17998	C66767		Action Taken with Study Treatment	UNKNOWN	U; UNK; Unknown	Not known, not observed, not recorded, or refused. (NCI)	Unknown
C66781		No	Age Unit	AGEU	Age Unit	Those units of time that are routinely used to express the age of a subject.	CDISC SDTM Age Unit Terminology
C25301	C66781		Age Unit	DAYS		A unit of measurement of time equal to 24 hours.	Day
C25529	C66781		Age Unit	HOURS	h; Hours; hr	A unit of measurement of time equal to 60 minutes.	Hour
C29846	C66781		Age Unit	MONTHS	Month	One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks. (NCI)	Month
C29844	C66781		Age Unit	WEEKS	Week	Any period of seven consecutive days. (NCI)	Week
C29848	C66781		Age Unit	YEARS	Year	The period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period. (NCI)	Year
C66726		Yes	Dosage Form	FRM	Dosage Form	A terminology codelist relevant to the physical form of the administered drug, substance, or product.	CDISC SDTM Dosage Form Terminology
C25158	C66726		Dosage Form	CAPSULE	cap	A solid pharmaceutical dosage form that contains medicinal agent within either a hard or soft soluble container or shell, usually used for the oral administration of medicine. The shells are made of a suitable form of gelatin or other substance. (NCI)	Capsule Dosage Form
C28944	C66726		Dosage Form	CREAM		A semisolid emulsion of either the oil-in-water or the water-in-oil type, ordinarily intended for topical use. (NCI)	Cream Dosage Form
C42946	C66726		Dosage Form	INJECTION		A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP. (NCI)	Injectable Dosage Form
C42986	C66726		Dosage Form	SOLUTION		A clear, homogeneous liquid dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior.	Solution Dosage Form
C42998	C66726		Dosage Form	TABLET	tab	A solid dosage form containing medicinal substances with or without suitable diluents. (NCI)	Tablet Dosage Form
C99079		Yes	Epoch	EPOCH	Epoch	The name of the EPOCH.	CDISC SDTM Epoch Terminology
C125938	C99079		Epoch	BASELINE		A period in a clinical study after eligibility has been met and before the start of treatment, at which baseline measurements are collected.	Baseline Epoch
C102255	C99079		Epoch	BLINDED TREATMENT		A period in a clinical study during which subjects receive blinded therapeutic treatment.	Blinded Treatment Epoch
C123452	C99079		Epoch	CONTINUATION TREATMENT	Continuation Phase	A period in a clinical study during which subjects receive continuation treatment.	Continuation Therapy Epoch
C202578	C99079		Epoch	FOLLOW-UP		A period in a clinical study during which information about the health status of an individual is obtained after study interventions have concluded.	Follow-Up Epoch
C123453	C99079		Epoch	INDUCTION TREATMENT	Induction Phase; Intensive Phase	A period in a clinical study during which subjects receive induction treatment.	Induction Therapy Epoch
C209541	C99079		Epoch	INTERVENTION		A period in a study during which subjects are receiving investigational intervention(s).	Investigational Intervention Epoch
C202577	C99079		Epoch	LONG-TERM FOLLOW-UP		A period in a clinical study during which information about the health status of an individual is obtained long after study interventions have concluded.	Long-term Follow-up Epoch
C165873	C99079		Epoch	OBSERVATION		A period in a clinical study during which subjects are observed, without any planned intervention.	Observation Study Epoch
C102256	C99079		Epoch	OPEN LABEL TREATMENT		A period in a clinical study during which subjects receive open label therapeutic treatment.	Open Label Treatment Epoch
C199844	C99079		Epoch	PRE-SCREENING		A period in a clinical study during which subjects are evaluated prior to entering the full screening period.	Pre-Screening Epoch
C210380	C99079		Epoch	PRODUCT EXPOSURE		A period in a clinical study during which subjects are exposed to the product.	Product Exposure Epoch
C98779	C99079		Epoch	RUN-IN		A period in a clinical study that occurs after screening and before randomization, during which the subject is further evaluated and/or prepared for the commencement of the clinical study investigation.	Run-in Period
C202487	C99079		Epoch	SCREENING		A period in a clinical study during which subjects are evaluated for participation in the study.	Screening Epoch
C101526	C99079		Epoch	TREATMENT		A period in a study during which subjects are receiving investigational therapy or treatment.	Treatment Epoch
C42872	C99079		Epoch	WASHOUT		The interval of time that a participant enrolled in a study must not receive a specified treatment(s) before starting a study intervention(s). (CDISC Glossary)	Washout Period
C65047		Yes	Laboratory Test Code	LBTESTCD	Laboratory Test Code	Terminology used for laboratory test codes of the CDISC Study Data Tabulation Model.	CDISC SDTM Laboratory Test Code Terminology
C64431	C65047		Laboratory Test Code	ALB	Albumin; Microalbumin	A measurement of the albumin protein in a biological specimen.	Albumin Measurement
C64432	C65047		Laboratory Test Code	ALP	Alkaline Phosphatase	A measurement of the alkaline phosphatase in a biological specimen.	Alkaline Phosphatase Measurement
C64433	C65047		Laboratory Test Code	ALT	Alanine Aminotransferase; SGPT	A measurement of the alanine aminotransferase in a biological specimen.	Alanine Aminotransferase Measurement
C64467	C65047		Laboratory Test Code	AST	Aspartate Aminotransferase; Aspartate Aminotransferase Antigen; SGOT; SGOT Antigen	A measurement of the aspartate aminotransferase in a biological specimen.	Aspartate Aminotransferase Measurement
C38037	C65047		Laboratory Test Code	BILI	Bilirubin; Total Bilirubin	A measurement of the total bilirubin in a biological specimen.	Total Bilirubin Measurement
C64488	C65047		Laboratory Test Code	CA	Calcium	A measurement of the calcium in a biological specimen.	Calcium Measurement
C105586	C65047		Laboratory Test Code	CHOL	Cholesterol; Total Cholesterol	A measurement of the cholesterol in a biological specimen.	Cholesterol Measurement
C64495	C65047		Laboratory Test Code	CL	Chloride	A measurement of the chloride in a biological specimen.	Chloride Measurement
C64547	C65047		Laboratory Test Code	CREAT	Creatinine	A measurement of the creatinine in a biological specimen.	Creatinine Measurement
C64548	C65047		Laboratory Test Code	CRP	C Reactive Protein	A measurement of the C reactive protein in a biological specimen.	C-Reactive Protein Measurement
C64847	C65047		Laboratory Test Code	GGT	Gamma Glutamyl Transferase	A measurement of the gamma glutamyl transferase in a biological specimen.	Gamma Glutamyl Transpeptidase Measurement
C105585	C65047		Laboratory Test Code	GLUC	Glucose	A measurement of the glucose in a biological specimen.	Glucose Measurement
C64849	C65047		Laboratory Test Code	HBA1C	HbA1c; Hemoglobin A1C	A measurement of the glycated hemoglobin A1C in a biological specimen.	Hemoglobin A1C Measurement
C64796	C65047		Laboratory Test Code	HCT	Erythrocyte Volume Fraction; EVF; Hematocrit; Packed Cell Volume; PCV	The percentage of a whole blood specimen that is composed of red blood cells (erythrocytes).	Hematocrit Measurement
C105587	C65047		Laboratory Test Code	HDL	HDL Cholesterol	A measurement of the high density lipoprotein cholesterol in a biological specimen.	High Density Lipoprotein Cholesterol Measurement
C64848	C65047		Laboratory Test Code	HGB	Hemoglobin; Hemoglobin Monomer	A measurement of the total erythrocyte associated hemoglobin in a biological specimen.	Hemoglobin Measurement
C64853	C65047		Laboratory Test Code	K	Potassium	A measurement of the potassium in a biological specimen.	Potassium Measurement
C64855	C65047		Laboratory Test Code	LDH	Lactate Dehydrogenase	A measurement of the lactate dehydrogenase in a biological specimen.	Lactate Dehydrogenase Measurement
C105588	C65047		Laboratory Test Code	LDL	LDL Cholesterol	A measurement of the low density lipoprotein cholesterol in a biological specimen.	Low Density Lipoprotein Cholesterol Measurement
C64840	C65047		Laboratory Test Code	MG	Magnesium	A measurement of the magnesium in a biological specimen.	Magnesium Measurement
C64857	C65047		Laboratory Test Code	PHOS	Inorganic Phosphate; Phosphate; Phosphorus	A measurement of the phosphate in a biological specimen.	Phosphate Measurement
C51951	C65047		Laboratory Test Code	PLAT	Platelets	A measurement of the platelets (non-nucleated thrombocytes) in a biological specimen.	Platelet Count
C64858	C65047		Laboratory Test Code	PROT	Protein	A measurement of the total protein in a biological specimen.	Total Protein Measurement
C51946	C65047		Laboratory Test Code	RBC	Erythrocytes; Red Blood Cells	A measurement of the total erythrocytes in a biological specimen.	Erythrocyte Count
C64809	C65047		Laboratory Test Code	SODIUM	Sodium	A measurement of the sodium in a biological specimen.	Sodium Measurement
C64812	C65047		Laboratory Test Code	TRIG	Triglycerides	A measurement of the triglycerides in a biological specimen.	Triglyceride Measurement
C64814	C65047		Laboratory Test Code	URATE	Urate; Uric Acid	A measurement of the urate in a biological specimen.	Urate Measurement
C64815	C65047		Laboratory Test Code	UREA	Urea	A measurement of the urea in a biological specimen.	Urea Measurement
C51948	C65047		Laboratory Test Code	WBC	Leukocytes; White Blood Cells	A measurement of the leukocytes in a biological specimen.	Leukocyte Count
C67154		Yes	Laboratory Test Name	LBTEST	Laboratory Test Name	Terminology used for laboratory test names of the CDISC Study Data Tabulation Model.	CDISC SDTM Laboratory Test Name Terminology
C64433	C67154		Laboratory Test Name	Alanine Aminotransferase	Alanine Aminotransferase; SGPT	A measurement of the alanine aminotransferase in a biological specimen.	Alanine Aminotransferase Measurement
C64431	C67154		Laboratory Test Name	Albumin	Albumin; Microalbumin	A measurement of the albumin protein in a biological specimen.	Albumin Measurement
C64432	C67154		Laboratory Test Name	Alkaline Phosphatase	Alkaline Phosphatase	A measurement of the alkaline phosphatase in a biological specimen.	Alkaline Phosphatase Measurement
C64467	C67154		Laboratory Test Name	Aspartate Aminotransferase	Aspartate Aminotransferase; Aspartate Aminotransferase Antigen; SGOT; SGOT Antigen	A measurement of the aspartate aminotransferase in a biological specimen.	Aspartate Aminotransferase Measurement
C38037	C67154		Laboratory Test Name	Bilirubin	Bilirubin; Total Bilirubin	A measurement of the total bilirubin in a biological specimen.	Total Bilirubin Measurement
C64548	C67154		Laboratory Test Name	C Reactive Protein	C Reactive Protein	A measurement of the C reactive protein in a biological specimen.	C-Reactive Protein Measurement
C64488	C67154		Laboratory Test Name	Calcium	Calcium	A measurement of the calcium in a biological specimen.	Calcium Measurement
C64495	C67154		Laboratory Test Name	Chloride	Chloride	A measurement of the chloride in a biological specimen.	Chloride Measurement
C105586	C67154		Laboratory Test Name	Cholesterol	Cholesterol; Total Cholesterol	A measurement of the cholesterol in a biological specimen.	Cholesterol Measurement
C64547	C67154		Laboratory Test Name	Creatinine	Creatinine	A measurement of the creatinine in a biological specimen.	Creatinine Measurement
C51946	C67154		Laboratory Test Name	Erythrocytes	Erythrocytes; Red Blood Cells	A measurement of the total erythrocytes in a biological specimen.	Erythrocyte Count
C64847	C67154		Laboratory Test Name	Gamma Glutamyl Transferase	Gamma Glutamyl Transferase	A measurement of the gamma glutamyl transferase in a biological specimen.	Gamma Glutamyl Transpeptidase Measurement
C105585	C67154		Laboratory Test Name	Glucose	Glucose	A measurement of the glucose in a biological specimen.	Glucose Measurement
C105587	C67154		Laboratory Test Name	HDL Cholesterol	HDL Cholesterol	A measurement of the high density lipoprotein cholesterol in a biological specimen.	High Density Lipoprotein Cholesterol Measurement
C64796	C67154		Laboratory Test Name	Hematocrit	Erythrocyte Volume Fraction; EVF; Hematocrit; Packed Cell Volume; PCV	The percentage of a whole blood specimen that is composed of red blood cells (erythrocytes).	Hematocrit Measurement
C64849	C67154		Laboratory Test Name	Hemoglobin A1C	HbA1c; Hemoglobin A1C	A measurement of the glycated hemoglobin A1C in a biological specimen.	Hemoglobin A1C Measurement
C64848	C67154		Laboratory Test Name	Hemoglobin	Hemoglobin; Hemoglobin Monomer	A measurement of the total erythrocyte associated hemoglobin in a biological specimen.	Hemoglobin Measurement
C64855	C67154		Laboratory Test Name	Lactate Dehydrogenase	Lactate Dehydrogenase	A measurement of the lactate dehydrogenase in a biological specimen.	Lactate Dehydrogenase Measurement
C105588	C67154		Laboratory Test Name	LDL Cholesterol	LDL Cholesterol	A measurement of the low density lipoprotein cholesterol in a biological specimen.	Low Density Lipoprotein Cholesterol Measurement
C51948	C67154		Laboratory Test Name	Leukocytes	Leukocytes; White Blood Cells	A measurement of the leukocytes in a biological specimen.	Leukocyte Count
C64840	C67154		Laboratory Test Name	Magnesium	Magnesium	A measurement of the magnesium in a biological specimen.	Magnesium Measurement
C64857	C67154		Laboratory Test Name	Phosphate	Inorganic Phosphate; Phosphate; Phosphorus	A measurement of the phosphate in a biological specimen.	Phosphate Measurement
C51951	C67154		Laboratory Test Name	Platelets	Platelets	A measurement of the platelets (non-nucleated thrombocytes) in a biological specimen.	Platelet Count
C64853	C67154		Laboratory Test Name	Potassium	Potassium	A measurement of the potassium in a biological specimen.	Potassium Measurement
C64858	C67154		Laboratory Test Name	Protein	Protein	A measurement of the total protein in a biological specimen.	Total Protein Measurement
C64809	C67154		Laboratory Test Name	Sodium	Sodium	A measurement of the sodium in a biological specimen.	Sodium Measurement
C64812	C67154		Laboratory Test Name	Triglycerides	Triglycerides	A measurement of the triglycerides in a biological specimen.	Triglyceride Measurement
C64814	C67154		Laboratory Test Name	Urate	Urate; Uric Acid	A measurement of the urate in a biological specimen.	Urate Measurement
C125949	C67154		Laboratory Test Name	Urea Nitrogen	Urea Nitrogen	A measurement of the urea nitrogen in a biological specimen.	Urea Nitrogen Measurement
C66742		No	No Yes Response	NY	No Yes Response	A term that is used to indicate a question with permissible values of yes/no/unknown/not applicable.	CDISC SDTM Yes No Unknown or Not Applicable Response Terminology
C49487	C66742		No Yes Response	N	No	The non-affirmative response to a question. (NCI)	No
C48660	C66742		No Yes Response	NA	NA; Not Applicable	Determination of a value is not relevant in the current context. (NCI)	Not Applicable
C17998	C66742		No Yes Response	U	U; UNK; Unknown	Not known, not observed, not recorded, or refused. (NCI)	Unknown
C49488	C66742		No Yes Response	Y	Yes	The affirmative response to a question. (NCI)	Yes
C66768		No	Outcome of Event	OUT	Outcome of Event	A condition or event that is attributed to the adverse event and is the result or conclusion of the adverse event. (NCI)	CDISC SDTM Adverse Event Outcome Terminology
C48275	C66768		Outcome of Event	FATAL	5; FATAL; Grade 5	The termination of life as a result of an adverse event. (NCI)	Death Related to Adverse Event
C49494	C66768		Outcome of Event	NOT RECOVERED/NOT RESOLVED		One of the possible results of an adverse event outcome that indicates that the event has not improved or recuperated. (NCI)	Not Recovered from Adverse Event
C49495	C66768		Outcome of Event	RECOVERED/RESOLVED WITH SEQUELAE		One of the possible results of an adverse event outcome where the subject recuperated but retained pathological conditions resulting from the prior disease or injury. (NCI)	Recovered from Adverse Event with Sequelae
C49498	C66768		Outcome of Event	RECOVERED/RESOLVED		One of the possible results of an adverse event outcome that indicates that the event has improved or recuperated. (NCI)	Recovered from Adverse Event
C49496	C66768		Outcome of Event	RECOVERING/RESOLVING		One of the possible results of an adverse event outcome that indicates that the event is improving. (NCI)	Recovering or Resolving
C17998	C66768		Outcome of Event	UNKNOWN	U; UNK; Unknown	Not known, not observed, not recorded, or refused. (NCI)	Unknown
C71148		Yes	Position	POSITION	Position	Terminology codelist used with Body Position within CDISC.	CDISC SDTM Body Position Terminology
C111310	C71148		Position	SEMI-RECUMBENT	Semi-Supine	A semi-sitting or semi-reclined body position in which the head is elevated above horizontal. (NCI)	Semi-Recumbent
C62122	C71148		Position	SITTING	Sitting	The state or act of one who sits; the posture of one who occupies a seat. (NCI)	Sitting
C62166	C71148		Position	STANDING	Orthostatic; Standing	The act of assuming or maintaining an erect upright position. (NCI)	Standing
C62167	C71148		Position	SUPINE	Supine	A posterior recumbent body position whereby the person lies on its back and faces upward. (NCI)	Supine Position
C66729		Yes	Route of Administration Response	ROUTE	Route of Administration Response	A terminology codelist relevant to the pathway by which a substance is administered in order to reach the site of action in the body.	CDISC SDTM Route of Administration Terminology
C28161	C66729		Route of Administration Response	INTRAMUSCULAR		Administration within a muscle. (FDA)	Intramuscular Route of Administration
C38276	C66729		Route of Administration Response	INTRAVENOUS		Administration within or into a vein or veins. (FDA)	Intravenous Route of Administration
C38288	C66729		Route of Administration Response	ORAL	Intraoral Route of Administration; PO	Administration to or by way of the mouth. (FDA)	Oral Route of Administration
C38299	C66729		Route of Administration Response	SUBCUTANEOUS	SC; Subdermal Route of Administration	Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL. (FDA)	Subcutaneous Route of Administration
C38304	C66729		Route of Administration Response	TOPICAL	TOP	Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL. (FDA)	Topical Route of Administration
C66734		Yes	SDTM Domain Abbreviation	DOMAIN	SDTM Domain Abbreviation	Terminology related to the short name for a CDISC domain.	CDISC SDTM Submission Domain Abbreviation Terminology
C49562	C66734		SDTM Domain Abbreviation	AE	Adverse Events; Adverse Experiences	An events domain used for data describing unintended signs (including an abnormal laboratory finding, for example), symptoms, or diseases temporally associated with the defined study period.	Adverse Event Domain
C49568	C66734		SDTM Domain Abbreviation	CM	Concomitant/Prior Medications	An interventions domain that contains concomitant and prior medications used by the subject, such as those given on an as needed basis or condition-appropriate medications.	Concomitant Medication Domain
C49572	C66734		SDTM Domain Abbreviation	DM	Demographics	A special-purpose domain that includes a set of essential standard variables that describe each subject in a clinical or nonclinical study. One record will exist for each subject.	Demographics Domain
C49576	C66734		SDTM Domain Abbreviation	DS	Disposition	An events domain that contains information encompassing and representing data related to subject disposition.	Disposition Domain
C49587	C66734		SDTM Domain Abbreviation	EX	Exposure	An interventions domain that contains the details of a subject's exposure to protocol-specified study intervention or investigational product. Study interventions or Investigational products may be any intervention that is prospectively defined as a test material within a study, and is typically but not always supplied to the subject.	Exposure Domain
C49592	C66734		SDTM Domain Abbreviation	LB	Laboratory Test Results	A specimen-based findings domain that contains laboratory test data such as hematology, clinical chemistry and urinalysis. This domain does not include microbiology or pharmacokinetic data, which are stored in separate domains.	Laboratory Data Domain
C49603	C66734		SDTM Domain Abbreviation	MH	Medical History	An events domain that contains data that includes the subject's prior medical history at the start of the trial.	Medical History Domain
C49617	C66734		SDTM Domain Abbreviation	SV	Subject Visits	A special-purpose domain that contains information for each subject's actual and planned visits and contact events.	Subject Visits Domain
C53483	C66734		SDTM Domain Abbreviation	TS	Trial Summary	A trial design domain that contains one record for each trial summary characteristic.	Trial Summary Domain
C49622	C66734		SDTM Domain Abbreviation	VS	Vital Signs	A findings domain that contains data related to vital sign measurements.	Vital Signs Domain
C66769		No	Severity/Intensity Scale for Adverse Events	AESEV	Severity/Intensity Scale for Adverse Events	A scale that defines the degree or state of disease existing in a patient as a result of the occurrence of an adverse event. (NCI)	CDISC SDTM Severity Intensity Scale for Adverse Event Terminology
C41338	C66769		Severity/Intensity Scale for Adverse Events	MILD	1; Grade 1	A type of adverse event that is usually transient and may require only minimal treatment or therapeutic intervention. The event does not generally interfere with usual activities of daily living.	Mild Adverse Event
C41339	C66769		Severity/Intensity Scale for Adverse Events	MODERATE	2; Grade 2	A type of adverse event that is usually alleviated with additional specific therapeutic intervention. The event interferes with usual activities of daily living, causing discomfort but poses no significant or permanent risk of harm to the research participant.	Moderate Adverse Event
C41340	C66769		Severity/Intensity Scale for Adverse Events	SEVERE	3; Grade 3	A type of adverse event that interrupts usual activities of daily living, or significantly affects clinical status, or may require intensive therapeutic intervention.	Severe Adverse Event
C66731		No	Sex	SEX	Sex	A terminology codelist relevant to the assemblage of physical properties or qualities by which male is distinguished from female; the physical difference between male and female; the distinguishing peculiarity of male or female.	CDISC SDTM Sex of Individual Terminology
C16576	C66731		Sex	F	Female	A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. [The NCI Thesaurus contains biomedical terminologies that NCI does not own or control. This concept contains gender-related content that does not comply with Executive Order 14168.]	Female
C45908	C66731		Sex	INTERSEX		A person (one of unisexual specimens) who is born with genitalia and/or secondary sexual characteristics of indeterminate sex, or which combine features of both sexes. (NCI)	Intersex
C20197	C66731		Sex	M	Male	A person who belongs to the sex that normally produces sperm. The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both. [The NCI Thesaurus contains biomedical terminologies that NCI does not own or control. This concept contains gender-related content that does not comply with Executive Order 14168.]	Male
C17998	C66731		Sex	U	U; UNK; Unknown	Not known, not observed, not recorded, or refused. (NCI)	Unknown
C66735		Yes	Trial Blinding Schema Response	TBLIND	Trial Blinding Schema Response	A terminology codelist relevant to the type of experimental design used to describe the level of awareness of the study subjects and/ or study personnel as it relates to the respective intervention(s) or assessments being observed, received or administered.	CDISC SDTM Trial Blinding Schema Terminology
C15228	C66735		Trial Blinding Schema Response	DOUBLE BLIND	Double Masked; Double-Masked	A study in which neither the subject nor the study personnel interacting with the subject or data during the study knows what intervention a subject is receiving.	Double Blind Study
C49659	C66735		Trial Blinding Schema Response	OPEN LABEL		A study in which subjects and study personnel know which intervention each subject is receiving.	Open Label Study
C28233	C66735		Trial Blinding Schema Response	SINGLE BLIND	Single Masked; Single-Masked	A study in which one party, either the subject or study personnel, does not know which intervention is administered to the subject.	Single Blind Study
C66737		Yes	Trial Phase Response	TPHASE	Trial Phase Response	A terminology codelist relevant to a step in the clinical research and development of a therapy from initial clinical trials to post-approval studies.	CDISC SDTM Trial Phase Terminology
C15600	C66737		Trial Phase Response	PHASE I TRIAL	1; Trial Phase 1	The initial introduction of an investigational new drug into humans. Phase 1 studies are typically closely monitored and may be conducted in patients or normal volunteer subjects. NOTE: These studies are designed to determine the metabolism and pharmacologic actions of the drug in humans, the side effects associated with increasing doses, and, if possible, to gain early evidence on effectiveness. During Phase 1, sufficient information about the drug's pharmacokinetics and pharmacological effects should be obtained to permit the design of well-controlled, scientifically valid, Phase 2 studies. The total number of subjects and patients included in Phase I studies varies with the drug, but is generally in the range of 20 to 80. Phase 1 studies also include studies of drug metabolism, structure-activity relationships, and mechanism of action in humans, as well as studies in which investigational drugs are used as research tools to explore biological phenomena or disease processes. [After FDA CDER Handbook, ICH E8] (CDISC glossary)	Phase I Trial
C15601	C66737		Trial Phase Response	PHASE II TRIAL	2; Trial Phase 2	Phase that includes the controlled clinical trials conducted to evaluate the safety and efficacy of the drug in a limited number of patients with the disease or condition under study. Objectives can be dose-ranging (dose-response, frequency of dosing), type of patients, or numerous other characteristics of safety and efficacy. [After 21 CRF Part 312.21 Phases of an investigation] See also phase, phase 2a, phase 2b. (CDISC Glossary)	Phase II Trial
C15694	C66737		Trial Phase Response	PHASE II/III TRIAL	2-3; Trial Phase 2-3	A class of clinical study that combines elements characteristic of traditional Phase II and Phase III trials.	Phase II/III Trial
C15602	C66737		Trial Phase Response	PHASE III TRIAL	3; Trial Phase 3	Phase that includes the controlled clinical trials intended to confirm safety and effectiveness, evaluate the overall benefit-risk relationship, and to provide substantial evidence for regulatory approval and labeling. NOTE: Phase 3 studies usually include from several hundred to several thousand subjects. [After ICH E8; Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products Draft Guidance for Industry. December 2019] See also phase, phase 3b. (CDISC Glossary)	Phase III Trial
C15603	C66737		Trial Phase Response	PHASE IV TRIAL	4; Trial Phase 4	Post-approval studies to delineate additional information about the drug's risks, benefits, and optimal use that may be requested by regulatory authorities in conjunction with marketing approval. NOTE: Phase 4 studies could include, but would not be limited to, studying different doses or schedules of administration than were used in Phase 2 studies, use of the drug in other patient populations or other stages of the disease, or use of the drug over a longer period of time. [after FDA CDER handbook, ICH E8] See also phase. (CDISC Glossary)	Phase IV Trial
C66738		Yes	Trial Summary Parameter Test Code	TSPARMCD	Trial Summary Parameter Test Code	The test code for an individual characteristic of a clinical trial, e.g. description of trial design, trial blinding schema, and primary objective of trial.	CDISC SDTM Trial Summary Parameter Short Name Terminology
C49703	C66738		Trial Summary Parameter Test Code	ADDON	Added on to Existing Treatments	The addition of a therapeutic or other study product to the existing regimen in a study, where both entities remain as discrete products.	Test Product Added to Existing Treatment
C49694	C66738		Trial Summary Parameter Test Code	AGEMAX	Planned Maximum Age of Subjects	The anticipated maximum age of the subjects to be entered in a clinical trial. (NCI)	Planned Maximum Age of Subjects
C49693	C66738		Trial Summary Parameter Test Code	AGEMIN	Planned Minimum Age of Subjects	The anticipated minimum age of the subjects to be entered in a clinical trial. (NCI)	Planned Minimum Age of Subjects
C68612	C66738		Trial Summary Parameter Test Code	COMPTRT	Comparative Treatment Name	A therapeutically active agent that is intended to provide reference measurements for the experimental protocol of a clinical trial.	Active Comparator Drug
C85582	C66738		Trial Summary Parameter Test Code	CURTRT	Background Treatment; Current Therapy or Treatment	The name of a protocol-specified background treatment(s), that is (are) a medication currently being taken as a standard of care for a particular condition/disease.	Current Therapy
C98718	C66738		Trial Summary Parameter Test Code	DCUTDESC	Data Cutoff Description	Text that describes the cutoff date.	Data Cutoff Date Description
C98717	C66738		Trial Summary Parameter Test Code	DCUTDTC	Data Cutoff Date	A date which indicates any data collected by this date will be used for analysis.	Data Cutoff Date
C112038	C66738		Trial Summary Parameter Test Code	INDIC	Indication for Use; Trial Disease/Condition Indication; Trial Disease/Condition Indication Description	A narrative representation of the condition, disease or disorder that the clinical trial is intended to investigate or address.	Trial Indication
C49697	C66738		Trial Summary Parameter Test Code	LENGTH	Trial Length	Planned length of observation for a single subject.	Trial Length
C98771	C66738		Trial Summary Parameter Test Code	NARMS	Planned Number of Arms	The planned number of intervention groups.	Planned Number of Arms
C85826	C66738		Trial Summary Parameter Test Code	OBJPRIM	Study Primary Objective; Trial Primary Objective	The main scientific question(s) the study is designed to answer. (CDISC Glossary)	Trial Primary Objective
C98768	C66738		Trial Summary Parameter Test Code	PCLAS	Pharmacologic Class	The pharmacological class of the investigational product.	Pharmacological Class of Investigational Therapy
C49692	C66738		Trial Summary Parameter Test Code	PLANSUB	Anticipated Enrollment; Planned Enrollment; Planned Number of Subjects; Target Enrollment	The planned number of subjects intended to be enrolled within a study to reach a pre-specified sample size (in any cohort or the entire study).	Planned Subject Number
C25196	C66738		Trial Summary Parameter Test Code	RANDOM	Trial is Randomized	The process of assigning trial subjects to treatment or control groups using an element of chance to determine the assignments in order to reduce bias. NOTE: Unequal randomization is used to allocate subjects into groups at a differential rate; for example, three subjects may be assigned to a treatment group for every one assigned to the control group. [ICH E6 1.48] See also balanced study. (CDISC glossary)	Randomization
C98775	C66738		Trial Summary Parameter Test Code	RANDQT	Randomization Quotient	The randomization quotient is the number of planned subjects to be exposed to investigational therapy, independent of dose or other factors, divided by the total number of planned subjects.	Randomization Quotient
C90462	C66738		Trial Summary Parameter Test Code	SENDTC	Study End Date	The date on which the final data item for a clinical study was collected from the last study participant (that is, last subject, last visit, or as otherwise defined in the study protocol). (CDISC Glossary)	Clinical Study End Date
C49696	C66738		Trial Summary Parameter Test Code	SEXPOP	Sex of Participants	The specific sex, either male, female, or mixed of the subject group being studied. (NCI)	Sex of Study Group
C70793	C66738		Trial Summary Parameter Test Code	SPONSOR	Clinical Study Sponsor; Sponsor; Study Sponsor	An individual, company, institution, or organization that takes responsibility for the initiation, management, and/or financing of a clinical study. [After ICH E6, WHO, 21 CFR 50.3 (e), and after IDMP]	Clinical Study Sponsor
C69208	C66738		Trial Summary Parameter Test Code	SSTDTC	Study Start Date	The earliest date of informed consent among any subject (Date/Time of Informed Consent, RFICDTC) that enrolled in the study. For studies conducted without informed consent (i.e., emergency use) use the date of treatment. Dates for subjects who were screen failures are not included. [After US FDA, Providing Regulatory Submissions In Electronic Format - Standardized Study Data Guidance for Industry, June 2021]	Study Start Date
C142175	C66738		Trial Summary Parameter Test Code	STYPE	Study Type; Study Type Classification	The nature of the investigation for which study information is being collected. (After clinicaltrials.gov)	Study Type
C49658	C66738		Trial Summary Parameter Test Code	TBLIND	Study Blinding Design; Study Blinding Schema; Study Masking Design; Trial Blinding Design; Trial Blinding Schema; Trial Masking Design	The type of experimental design used to describe the level of awareness of the study subjects and/ or study personnel as it relates to the respective intervention(s) or assessments being observed, received or administered.	Trial Blinding Schema
C49802	C66738		Trial Summary Parameter Test Code	TITLE	Official Study Title; Study Title; Trial Title	The sponsor-defined name of the clinical study.	Trial Title
C48281	C66738		Trial Summary Parameter Test Code	TPHASE	Trial Phase; Trial Phase Classification	A step in the clinical research and development of a therapy from initial clinical trials to post-approval studies. NOTE: Clinical trials are generally categorized into four (sometimes five) phases. A therapeutic intervention may be evaluated in two or more phases simultaneously in different trials, and some trials may overlap two different phases. [21 CFR section 312.21; After ICH Topic E8 NOTE FOR GUIDANCE ON GENERAL CONSIDERATIONS FOR CLINICAL TRIALS, CPMP/ICH/291/95 March 1998]	Trial Phase
C41161	C66738		Trial Summary Parameter Test Code	TRT	Investigational Interventional; Investigational Therapy or Treatment	The drug, device, therapy, procedure, or process under investigation in a clinical study that is believed to have an effect on outcomes of interest in a study (e.g., health-related quality of life, efficacy, safety, pharmacoeconomics). [After https://grants.nih.gov/grants/policy/faq_clinical_trial_definition.htm#5224; https://grants.nih.gov/policy/clinical-trials/protocol-template.htm] See also test articles, devices, drug product, combination product, treatment, diagnosis. Contrast with investigational medicinal product.	Protocol Agent
C67152		Yes	Trial Summary Parameter Test Name	TSPARM	Trial Summary Parameter Test Name	The test name for an individual characteristic of a clinical trial, e.g. description of trial design, trial blinding schema, and primary objective of trial.	CDISC SDTM Trial Summary Parameter Long Name Terminology
C49703	C67152		Trial Summary Parameter Test Name	Added on to Existing Treatments	Added on to Existing Treatments	The addition of a therapeutic or other study product to the existing regimen in a study, where both entities remain as discrete products.	Test Product Added to Existing Treatment
C68612	C67152		Trial Summary Parameter Test Name	Comparative Treatment Name	Comparative Treatment Name	A therapeutically active agent that is intended to provide reference measurements for the experimental protocol of a clinical trial.	Active Comparator Drug
C85582	C67152		Trial Summary Parameter Test Name	Current Therapy or Treatment	Background Treatment; Current Therapy or Treatment	The name of a protocol-specified background treatment(s), that is (are) a medication currently being taken as a standard of care for a particular condition/disease.	Current Therapy
C98717	C67152		Trial Summary Parameter Test Name	Data Cutoff Date	Data Cutoff Date	A date which indicates any data collected by this date will be used for analysis.	Data Cutoff Date
C98718	C67152		Trial Summary Parameter Test Name	Data Cutoff Description	Data Cutoff Description	Text that describes the cutoff date.	Data Cutoff Date Description
C41161	C67152		Trial Summary Parameter Test Name	Investigational Therapy or Treatment	Investigational Interventional; Investigational Therapy or Treatment	The drug, device, therapy, procedure, or process under investigation in a clinical study that is believed to have an effect on outcomes of interest in a study (e.g., health-related quality of life, efficacy, safety, pharmacoeconomics). [After https://grants.nih.gov/grants/policy/faq_clinical_trial_definition.htm#5224; https://grants.nih.gov/policy/clinical-trials/protocol-template.htm] See also test articles, devices, drug product, combination product, treatment, diagnosis. Contrast with investigational medicinal product.	Protocol Agent
C98768	C67152		Trial Summary Parameter Test Name	Pharmacologic Class	Pharmacologic Class	The pharmacological class of the investigational product.	Pharmacological Class of Investigational Therapy
C49694	C67152		Trial Summary Parameter Test Name	Planned Maximum Age of Subjects	Planned Maximum Age of Subjects	The anticipated maximum age of the subjects to be entered in a clinical trial. (NCI)	Planned Maximum Age of Subjects
C49693	C67152		Trial Summary Parameter Test Name	Planned Minimum Age of Subjects	Planned Minimum Age of Subjects	The anticipated minimum age of the subjects to be entered in a clinical trial. (NCI)	Planned Minimum Age of Subjects
C98771	C67152		Trial Summary Parameter Test Name	Planned Number of Arms	Planned Number of Arms	The planned number of intervention groups.	Planned Number of Arms
C49692	C67152		Trial Summary Parameter Test Name	Planned Number of Subjects	Anticipated Enrollment; Planned Enrollment; Planned Number of Subjects; Target Enrollment	The planned number of subjects intended to be enrolled within a study to reach a pre-specified sample size (in any cohort or the entire study).	Planned Subject Number
C49696	C67152		Trial Summary Parameter Test Name	Sex of Participants	Sex of Participants	The specific sex, either male, female, or mixed of the subject group being studied. (NCI)	Sex of Study Group
C90462	C67152		Trial Summary Parameter Test Name	Study End Date	Study End Date	The date on which the final data item for a clinical study was collected from the last study participant (that is, last subject, last visit, or as otherwise defined in the study protocol). (CDISC Glossary)	Clinical Study End Date
C69208	C67152		Trial Summary Parameter Test Name	Study Start Date	Study Start Date	The earliest date of informed consent among any subject (Date/Time of Informed Consent, RFICDTC) that enrolled in the study. For studies conducted without informed consent (i.e., emergency use) use the date of treatment. Dates for subjects who were screen failures are not included. [After US FDA, Providing Regulatory Submissions In Electronic Format - Standardized Study Data Guidance for Industry, June 2021]	Study Start Date
C142175	C67152		Trial Summary Parameter Test Name	Study Type	Study Type; Study Type Classification	The nature of the investigation for which study information is being collected. (After clinicaltrials.gov)	Study Type
C49658	C67152		Trial Summary Parameter Test Name	Trial Blinding Schema	Study Blinding Design; Study Blinding Schema; Study Masking Design; Trial Blinding Design; Trial Blinding Schema; Trial Masking Design	The type of experimental design used to describe the level of awareness of the study subjects and/ or study personnel as it relates to the respective intervention(s) or assessments being observed, received or administered.	Trial Blinding Schema
C25196	C67152		Trial Summary Parameter Test Name	Trial is Randomized	Trial is Randomized	The process of assigning trial subjects to treatment or control groups using an element of chance to determine the assignments in order to reduce bias. NOTE: Unequal randomization is used to allocate subjects into groups at a differential rate; for example, three subjects may be assigned to a treatment group for every one assigned to the control group. [ICH E6 1.48] See also balanced study. (CDISC glossary)	Randomization
C49697	C67152		Trial Summary Parameter Test Name	Trial Length	Trial Length	Planned length of observation for a single subject.	Trial Length
C48281	C67152		Trial Summary Parameter Test Name	Trial Phase Classification	Trial Phase; Trial Phase Classification	A step in the clinical research and development of a therapy from initial clinical trials to post-approval studies. NOTE: Clinical trials are generally categorized into four (sometimes five) phases. A therapeutic intervention may be evaluated in two or more phases simultaneously in different trials, and some trials may overlap two different phases. [21 CFR section 312.21; After ICH Topic E8 NOTE FOR GUIDANCE ON GENERAL CONSIDERATIONS FOR CLINICAL TRIALS, CPMP/ICH/291/95 March 1998]	Trial Phase
C85826	C67152		Trial Summary Parameter Test Name	Trial Primary Objective	Study Primary Objective; Trial Primary Objective	The main scientific question(s) the study is designed to answer. (CDISC Glossary)	Trial Primary Objective
C49802	C67152		Trial Summary Parameter Test Name	Trial Title	Official Study Title; Study Title; Trial Title	The sponsor-defined name of the clinical study.	Trial Title
C71620		Yes	Unit	UNIT	Unit	Terminology codelist used for units within CDISC.	CDISC SDTM Unit of Measure Terminology
C25613	C71620		Unit	%	Percentage	One hundred times the quotient of one quantity divided by another, with the same units of measurement.	Percentage
C67308	C71620		Unit	10^12/L	/pL; 1/pL; 10^6/mm3; 10^6/uL; M/uL; Mill/mcL; T/L; Tera/L; TI/L	A unit of measurement equal to 10 to the twelfth power of the number of entities per unit of volume equal to one liter.	Million per Microliter
C67255	C71620		Unit	10^9/L	/nL; 1/nL; 10^3/mm3; 10^3/uL; 10^6/mL; G/L; GI/L; Giga per Liter; Giga/L; K/cumm; Thou/mcL	A unit of measurement equal to 10 to the ninth power of the number of entities per unit of volume equal to one liter.	Billion per Liter
C49673	C71620		Unit	beats/min	Beats per Minute; BPM; bpm	The number of heartbeats measured per minute time. (NCI)	Beats per Minute
C42559	C71620		Unit	C	Degree Celsius	A unit of temperature of the temperature scale designed so that the freezing point of water is 0 degrees and the boiling point is 100 degrees at standard atmospheric pressure. The current official definition of the Celsius sets 0.01 C to be at the triple point of water and a degree to be 1/273.16 of the difference in temperature between the triple point of water and absolute zero. One degree Celsius represents the same temperature difference as one Kelvin. (NCI)	Degree Celsius
C49668	C71620		Unit	cm	Centimeter	A basic unit of length equal to one hundredth of a meter or approximately 0.393700787 inch.	Centimeter
C44277	C71620		Unit	F	Degree Fahrenheit	The Fahrenheit temperature scale is named after the German physicist Gabriel Fahrenheit (1686-1736), who proposed it in 1724. In this scale, the freezing point of water is 32 degrees Fahrenheit and the boiling point is 212 degrees, placing the boiling and melting points of water 180 degrees apart. In this scale a degree Fahrenheit is 5/9ths of a Kelvin (or of a degree Celsius), and minus 40 degrees Fahrenheit is equal to minus 40 degrees Celsius. (NCI)	Degree Fahrenheit
C64783	C71620		Unit	g/dL	g%; Gram per Deciliter	A unit of mass concentration defined as the concentration of one gram of a substance per unit volume of the mixture equal to one deciliter (100 milliliters). The concept also refers to the metric unit of mass density (volumic mass) defined as the density of substance which mass equal to one gram occupies the volume one deciliter.(NCI)	Gram per Deciliter
C42576	C71620		Unit	g/L	g/L; Gram per Liter; kg/m3; Kilogram per Cubic Meter; mg/mL; Microgram per Microliter; Milligram per Milliliter; ug/uL	A unit of concentration or mass density equal to one milligram of substance per milliliter of solution or one gram of substance per liter of solution.	Kilogram per Cubic Meter
C48500	C71620		Unit	in	Inch	A traditional unit of length equal to 2.54 centimeters. (NCI)	Inch
C67376	C71620		Unit	IU/L	IE/L; International Unit per Liter; IU/L; mIU/mL	A unit of concentration (biologic activity) equal to one milli-international unit of substance per milliliter of solution or one international unit of substance per liter of solution.	International Unit per Liter
C28252	C71620		Unit	kg	Kilogram	The base unit of mass in the International System of Units (SI) equal to the mass of the international prototype kilogram, a platinum-iridium cylinder in the custody of the International Bureau of Weights and Measures.	Kilogram
C48531	C71620		Unit	LB	lb; lb_av; Pound	A traditional unit of mass. By international agreement, one avoirdupois pound is equal to exactly 0.453 592 37 kilogram, 16 ounces, or 1.215 28 troy pounds. (NCI)	Pound
C67474	C71620		Unit	mEq/L	Milliequivalent Per Liter; Millivalent per Liter; mval/L	A concentration unit measured as a number of milliequivalents of solute per liter of solution.(NCI)	Milliequivalent per Liter
C28253	C71620		Unit	mg	Milligram	A unit of mass equal to one thousandth (1E-3) of a gram.	Milligram
C67015	C71620		Unit	mg/dL	mg%; Milligram per Deciliter	A unit of mass concentration defined as the concentration of one milligram of a substance in unit volume of the mixture equal to one cubic deciliter or 100 cubic centimeters. It is also a unit of mass density (volumic mass) defined as the density of substance which mass equal to one milligram occupies the volume one cubic deciliter or 100 cubic centimeters.(NCI)	Milligram per Deciliter
C64572	C71620		Unit	mg/L	g/m3; Gram per Cubic Meter; mcg/mL; mg/L; Microgram per Milliliter; Milligram per Liter; ng/uL; ug/mL	A unit of concentration or mass density equal to one microgram of substance per milliliter of solution or one milligram of substance per liter of solution.	Microgram per Milliliter
C49670	C71620		Unit	mmHg	Millimeter of Mercury	A unit of pressure equal to 0.001316 atmosphere and equal to the pressure indicated by one millimeter rise of mercury in a barometer at the Earth's surface. (NCI)	Millimeter of Mercury
C64387	C71620		Unit	mmol/L	mcmol/mL; Micromole per Milliliter; Millimole per Liter; mmol/L; mol/m3; Mole per Cubic Meter; nmol/uL; umol/mL	A unit of concentration (molarity unit) equal to one millimole of solute per liter of solution.	Millimole per Liter
C111253	C71620		Unit	mmol/mol	umol/mmol	A unit of fraction expressed as the ratio of the amount of a substance in solution, in millimoles, to the amount of a different substance in the mixture, in moles.	Millimole per Mole
C67456	C71620		Unit	U/L	mU/mL; Unit per Liter	A unit of substance concentration equal to the concentration at which one liter of mixture contains one unit of a substance.	Unit per Liter
C67306	C71620		Unit	ug/L	mcg/L; mg/m3; Microgram per Liter; Milligram per Cubic Meter; Nanogram per Milliliter; ng/mL; ug/L	A unit of concentration or mass density equal to one nanogram of substance per milliliter of solution or one microgram of substance per liter of solution.	Microgram per Liter
C48508	C71620		Unit	umol/L	nmol/mL	A unit of concentration (molarity unit) equal to one micromole of solute per liter of solution.	Micromole per Liter
C66770		Yes	Units for Vital Signs Results	VSRESU	Units for Vital Signs Results	The unit used to record and describe the result of a test investigating a vital sign. (NCI)	CDISC SDTM Unit for Vital Sign Result Terminology
C49673	C66770		Units for Vital Signs Results	beats/min	Beats per Minute; BPM; bpm	The number of heartbeats measured per minute time. (NCI)	Beats per Minute
C42559	C66770		Units for Vital Signs Results	C	Degree Celsius	A unit of temperature of the temperature scale designed so that the freezing point of water is 0 degrees and the boiling point is 100 degrees at standard atmospheric pressure. The current official definition of the Celsius sets 0.01 C to be at the triple point of water and a degree to be 1/273.16 of the difference in temperature between the triple point of water and absolute zero. One degree Celsius represents the same temperature difference as one Kelvin. (NCI)	Degree Celsius
C49668	C66770		Units for Vital Signs Results	cm	Centimeter	A basic unit of length equal to one hundredth of a meter or approximately 0.393700787 inch.	Centimeter
C44277	C66770		Units for Vital Signs Results	F	Degree Fahrenheit	The Fahrenheit temperature scale is named after the German physicist Gabriel Fahrenheit (1686-1736), who proposed it in 1724. In this scale, the freezing point of water is 32 degrees Fahrenheit and the boiling point is 212 degrees, placing the boiling and melting points of water 180 degrees apart. In this scale a degree Fahrenheit is 5/9ths of a Kelvin (or of a degree Celsius), and minus 40 degrees Fahrenheit is equal to minus 40 degrees Celsius. (NCI)	Degree Fahrenheit
C48500	C66770		Units for Vital Signs Results	in	Inch	A traditional unit of length equal to 2.54 centimeters. (NCI)	Inch
C28252	C66770		Units for Vital Signs Results	kg	Kilogram	The base unit of mass in the International System of Units (SI) equal to the mass of the international prototype kilogram, a platinum-iridium cylinder in the custody of the International Bureau of Weights and Measures.	Kilogram
C48531	C66770		Units for Vital Signs Results	LB	lb; lb_av; Pound	A traditional unit of mass. By international agreement, one avoirdupois pound is equal to exactly 0.453 592 37 kilogram, 16 ounces, or 1.215 28 troy pounds. (NCI)	Pound
C49670	C66770		Units for Vital Signs Results	mmHg	Millimeter of Mercury	A unit of pressure equal to 0.001316 atmosphere and equal to the pressure indicated by one millimeter rise of mercury in a barometer at the Earth's surface. (NCI)	Millimeter of Mercury
C66741		Yes	Vital Signs Test Code	VSTESTCD	Vital Signs Test Code	The test code given to the test that analyzes a particular set of vital signs including temperature, respiratory rate, heart rate, and blood pressure.	CDISC SDTM Vital Sign Test Code Terminology
C16358	C66741		Vital Signs Test Code	BMI	Body Mass Index	A general indicator of the body fat an individual is carrying based upon the ratio of weight to height. (NCI)	Body Mass Index
C25299	C66741		Vital Signs Test Code	DIABP	Diastolic Blood Pressure	The minimum blood pressure in the systemic arterial circulation during the cardiac cycle.	Diastolic Blood Pressure
C25347	C66741		Vital Signs Test Code	HEIGHT	Height	The vertical measurement or distance from the base to the top of an object; the vertical dimension of extension. (NCI)	Height
C49676	C66741		Vital Signs Test Code	PULSE	Pulse Rate	The rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomical sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot. (NCI)	Pulse Rate
C49678	C66741		Vital Signs Test Code	RESP	Respiratory Rate	The rate of breathing (inhalation and exhalation) measured within in a unit time, usually expressed as breaths per minute. (NCI)	Respiratory Rate
C25298	C66741		Vital Signs Test Code	SYSBP	Systolic Blood Pressure	The maximum blood pressure in the systemic arterial circulation during the cardiac cycle.	Systolic Blood Pressure
C174446	C66741		Vital Signs Test Code	TEMP	Body Temperature; Temperature	A measurement of the temperature of the body.	Body Temperature
C25208	C66741		Vital Signs Test Code	WEIGHT	Weight	The vertical force exerted by a mass as a result of gravity. (NCI)	Weight
C67153		Yes	Vital Signs Test Name	VSTEST	Vital Signs Test Name	The test name given to the test that analyzes a particular set of vital signs including temperature, respiratory rate, heart rate, and blood pressure.	CDISC SDTM Vital Sign Test Name Terminology
C16358	C67153		Vital Signs Test Name	Body Mass Index	Body Mass Index	A general indicator of the body fat an individual is carrying based upon the ratio of weight to height. (NCI)	Body Mass Index
C25299	C67153		Vital Signs Test Name	Diastolic Blood Pressure	Diastolic Blood Pressure	The minimum blood pressure in the systemic arterial circulation during the cardiac cycle.	Diastolic Blood Pressure
C25347	C67153		Vital Signs Test Name	Height	Height	The vertical measurement or distance from the base to the top of an object; the vertical dimension of extension. (NCI)	Height
C49676	C67153		Vital Signs Test Name	Pulse Rate	Pulse Rate	The rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomical sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot. (NCI)	Pulse Rate
C49678	C67153		Vital Signs Test Name	Respiratory Rate	Respiratory Rate	The rate of breathing (inhalation and exhalation) measured within in a unit time, usually expressed as breaths per minute. (NCI)	Respiratory Rate
C25298	C67153		Vital Signs Test Name	Systolic Blood Pressure	Systolic Blood Pressure	The maximum blood pressure in the systemic arterial circulation during the cardiac cycle.	Systolic Blood Pressure
C174446	C67153		Vital Signs Test Name	Temperature	Body Temperature; Temperature	A measurement of the temperature of the body.	Body Temperature
C25208	C67153		Vital Signs Test Name	Weight	Weight	The vertical force exerted by a mass as a result of gravity. (NCI)	Weight
